相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-125b and miR-155 Contribute to BCL2 Repression and Proliferation in Response to CD40 Ligand (CD154) in Human Leukemic B-cells
Shaun Willimott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Camptothecin Induces Apoptosis in Cancer Cells via MicroRNA-125b-Mediated Mitochondrial Pathways
Cheng-Wu Zeng et al.
MOLECULAR PHARMACOLOGY (2012)
Macrophage Infiltration Predicts a Poor Prognosis for Human Ewing Sarcoma
Toshifumi Fujiwara et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo
Feizhou Jiang et al.
BMC CANCER (2011)
Mechanism of Cell Adaptation When and How Do Cancer Cells Develop Chemoresistance?
Valentina Fodale et al.
CANCER JOURNAL (2011)
miR-125b Is Methylated and Functions as a Tumor Suppressor by Regulating the ETS1 Proto-oncogene in Human Invasive Breast Cancer
Yan Zhang et al.
CANCER RESEARCH (2011)
Negative regulation of the tumor suppressor p53 gene by microRNAs
M. Kumar et al.
ONCOGENE (2011)
miR-125b Promotes Growth of Prostate Cancer Xenograft Tumor Through Targeting Pro-Apoptotic Genes
Xu-Bao Shi et al.
PROSTATE (2011)
CD133 expression in chemo-resistant Ewing sarcoma cells
Xiaohua Jiang et al.
BMC CANCER (2010)
Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway
S. Kamura et al.
BRITISH JOURNAL OF CANCER (2010)
MicroRNA and drug resistance
J. Ma et al.
CANCER GENE THERAPY (2010)
Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing Family Tumors
Yan Li et al.
CANCER LETTERS (2010)
miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
Wei Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
Ming Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
MicroRNA miR-125a controls hematopoietic stem cell number
Shangqin Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MicroRNA-125b is a novel negative regulator of p53
Minh T. N. Le et al.
GENES & DEVELOPMENT (2009)
EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma
Jozef Ban et al.
CANCER RESEARCH (2008)
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Lin Xia et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma
Wenxi Li et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment
Agnieszka Rybak et al.
NATURE CELL BIOLOGY (2008)
An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells
Xu-Bao Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas
R. Visone et al.
ONCOGENE (2007)
Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples
Yaguang Xi et al.
RNA (2007)
Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells
Jinghuan Li et al.
BMC BIOTECHNOLOGY (2007)
Diagnosis and treatment of Ewing's sarcoma
Yukihide Iwamoto
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Involvement of P-glycoprotein and MRP1 in resistance to cyclic tetrapeptide subfamily of histone deacetylase inhibitors in the drug-resistant osteosarcoma and Ewing's sarcoma cells
T Okada et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors
K Scotlandi et al.
CANCER RESEARCH (2005)
Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin
H Ganjavi et al.
CANCER GENE THERAPY (2005)
Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex
JIJ Leu et al.
NATURE CELL BIOLOGY (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell Factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis
I González et al.
CLINICAL CANCER RESEARCH (2004)
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: Evaluation of combination ifosfamide and etoposide - A children's cancer group and pediatric oncology group study
JS Miser et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
c-kit receptor expression in Ewing's sarcoma:: Lack of prognostic value but therapeutic targeting opportunities in appropriate conditions
K Scotlandi et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma
AG Shankar et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2003)
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone
HE Grier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin
T Panaretakis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells
K Scotlandi et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Survival after recurrence of Ewing tumors - The St. Jude Children's Research Hospital experience, 1979-1999
C Rodriguez-Galindo et al.
CANCER (2002)
分享论文
